Toggle light / dark theme

Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial

In a randomized controlled trial in individuals with persistent atrial fibrillation, an individualized ablation procedure, in which areas with abnormal electrophysiological characteristics—as detected by an AI algorithm—were targeted for ablation, led to improved efficacy for reducing arrhythmia recurrence at 12 months following the ablation procedure.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.